British NHS patients soon to be treated in India
In a ground breaking move, the British government is to allow patients with non-emergency conditions to be treated in Indian hospitals under a scheme paid for by British taxpayers.
In a ground breaking move, the British government is to allow patients with non-emergency conditions to be treated in Indian hospitals under a scheme paid for by British taxpayers.
Staff at emergency rooms at hospitals will soon be able to monitor and reach patients in time thanks to scientists who have developed a novel integrated wireless system that monitors patients
Union Health Minister, Dr. Anbumani Ramadoss, currently on an official visit to France, discussed cooperation in certain fields such as Medical Research, Biotechnology, Development of vaccine, Promotion of Indian Systems of medicines and cooperation between ICMR and INSERM of France
Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.
To achieve the country�s health care objectives, the approach has to be inclusive of the ability to reach out to the bottom of the pyramid. Rural India is exposed to fundamental financial risks and has limited access to risk management solutions.
In the short term perspective health insurance industry is expected to grow at a rate of 25% annually till 2010, while in the long term, it is expected to grow at a rate of 5% annually thereafter.
India and other developing countries are set to lobby hard for funding mechanisms to develop medicines,
mostly aimed at neglected diseases such as tuberculosis and malaria, at a forum set up by the World Health Organization or WHO. Developed countries have long maintained that patents are sufficient incentive for innovation.
China’s Health Minister has announced an ambitious program to provide basic healthcare for every citizen in the world’s most populous nation.
In the next three years, India would move towards setting up a drug regulatory authority on the model of the US FDA, the country
The government has sought support from Non-resident Indians (NRIs) for the proposed state-funded health insurance cover scheme that is aimed at helping some 300 million people living below the poverty line (BPL) across India.
Cellworks Research India, the Bangalore-based research and development (R&D) wing of Cellworks Group Inc (California-headquartered company), has assisted Chennai-based Orchid Chemicals and Pharmaceuticals by providing system biology technology in carrying out ongoing New Chemical Entity (NCE) research programme.